NAT9 antibody
-
- Target See all NAT9 products
- NAT9 (N-Acetyltransferase 9 (NAT9))
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This NAT9 antibody is un-conjugated
-
Application
- Immunofluorescence (IF)
- Characteristics
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogen
- Recombinant fusion protein of human NAT9 (NP_056469.2).
- Isotype
- IgG
-
-
- Application Notes
- IF 1:50-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- NAT9 (N-Acetyltransferase 9 (NAT9))
- Alternative Name
- NAT9 (NAT9 Products)
- Synonyms
- EBSP, hNATL antibody, 1110028N05Rik antibody, N-acetyltransferase 9 (putative) antibody, N-acetyltransferase 9 (GCN5-related, putative) antibody, NAT9 antibody, Nat9 antibody
- Background
- NAT9 (N-Acetyltransferase 9 (Putative)) is a Protein Coding gene. Diseases associated with NAT9 include Lymphogranuloma Venereum and Granuloma Inguinale. Among its related pathways are Cytochrome P450 - arranged by substrate type. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring acyl groups other than amino-acyl groups and N-acetyltransferase activity.
- Gene ID
- 26151
- UniProt
- Q9BTE0
-